Prognostic Factors of Malignant Peritoneal Mesothelioma Experienced in Japanese Peritoneal Metastasis Center

The current standard of treatment for malignant peritoneal mesothelioma(MPM)is cytoreductive surgery(CRS)plus perioperative intraperitoneal or systemic chemotherapy(comprehensive treatment), The present study was performed to clarify the prognostic factors of PMP after comprehensive treatment. Among...

Full description

Saved in:
Bibliographic Details
Published inGan to kagaku ryoho Vol. 46; no. 2; p. 395
Main Authors Yonemura, Yutaka, Canbay, Emel, Wakama, Satoshi, Sako, Shouzou, Ishibashi, Haruaki, Hirano, Masamitsu, Motoi, Shunsuke, Mizumoto, Akiyoshi, Takao, Nobuyuki, Ichinose, Masumi, Noguchi, Kousuke, Liu, Yang, Fushida, Sachio
Format Journal Article
LanguageEnglish
Japanese
Published Japan 15.02.2019
Subjects
Online AccessGet more information

Cover

Loading…
Abstract The current standard of treatment for malignant peritoneal mesothelioma(MPM)is cytoreductive surgery(CRS)plus perioperative intraperitoneal or systemic chemotherapy(comprehensive treatment), The present study was performed to clarify the prognostic factors of PMP after comprehensive treatment. Among 63 patients with MPM, male and female patients were 34 and 29. CRSwas performed in 47 patients and complete cytoreduction(CC-0) was performed in 14(22%)patients. Mean numbers of resected peritoneal sectors and organs were 5.2(1-13), and 2.9(0- 9), respectively. Hyperthermic intraperitoneal chemoperfusion(HIPEC)was performed in 27 patients. Grade 1/2, Grade 3, and Grade 4 complications were experienced in 5, 6, and 3 patients, respectively. One patient died of sepsis, and the mortality rate was 2.3%. Independent prognostic factors for favorable prognosis were performance of HIPEC, peritoneal cancer index (PCI)score C12, no distant metastasis and histologic epithelial type. Relative risk of no HIPEC, PCI score B13, presence of distant metastasis and non epithelial type were 7.69, 22.1, 3.6 and 3.9, respectively. Risk factors for death after comprehensive treatment were no HIPEC, PCI score B13, and non epithelial type. However, only 11(17%)patients showed PCI score C12. Accordingly, PCI score should be reducedC12 before CRSby neoadjuvant chemotherapy.
AbstractList The current standard of treatment for malignant peritoneal mesothelioma(MPM)is cytoreductive surgery(CRS)plus perioperative intraperitoneal or systemic chemotherapy(comprehensive treatment), The present study was performed to clarify the prognostic factors of PMP after comprehensive treatment. Among 63 patients with MPM, male and female patients were 34 and 29. CRSwas performed in 47 patients and complete cytoreduction(CC-0) was performed in 14(22%)patients. Mean numbers of resected peritoneal sectors and organs were 5.2(1-13), and 2.9(0- 9), respectively. Hyperthermic intraperitoneal chemoperfusion(HIPEC)was performed in 27 patients. Grade 1/2, Grade 3, and Grade 4 complications were experienced in 5, 6, and 3 patients, respectively. One patient died of sepsis, and the mortality rate was 2.3%. Independent prognostic factors for favorable prognosis were performance of HIPEC, peritoneal cancer index (PCI)score C12, no distant metastasis and histologic epithelial type. Relative risk of no HIPEC, PCI score B13, presence of distant metastasis and non epithelial type were 7.69, 22.1, 3.6 and 3.9, respectively. Risk factors for death after comprehensive treatment were no HIPEC, PCI score B13, and non epithelial type. However, only 11(17%)patients showed PCI score C12. Accordingly, PCI score should be reducedC12 before CRSby neoadjuvant chemotherapy.
Author Hirano, Masamitsu
Ichinose, Masumi
Takao, Nobuyuki
Canbay, Emel
Liu, Yang
Sako, Shouzou
Wakama, Satoshi
Ishibashi, Haruaki
Yonemura, Yutaka
Motoi, Shunsuke
Mizumoto, Akiyoshi
Noguchi, Kousuke
Fushida, Sachio
Author_xml – sequence: 1
  givenname: Yutaka
  surname: Yonemura
  fullname: Yonemura, Yutaka
  organization: Japanese/Asian School of Peritoneal Surface Malignancy Treatment
– sequence: 2
  givenname: Emel
  surname: Canbay
  fullname: Canbay, Emel
– sequence: 3
  givenname: Satoshi
  surname: Wakama
  fullname: Wakama, Satoshi
– sequence: 4
  givenname: Shouzou
  surname: Sako
  fullname: Sako, Shouzou
– sequence: 5
  givenname: Haruaki
  surname: Ishibashi
  fullname: Ishibashi, Haruaki
– sequence: 6
  givenname: Masamitsu
  surname: Hirano
  fullname: Hirano, Masamitsu
– sequence: 7
  givenname: Shunsuke
  surname: Motoi
  fullname: Motoi, Shunsuke
– sequence: 8
  givenname: Akiyoshi
  surname: Mizumoto
  fullname: Mizumoto, Akiyoshi
– sequence: 9
  givenname: Nobuyuki
  surname: Takao
  fullname: Takao, Nobuyuki
– sequence: 10
  givenname: Masumi
  surname: Ichinose
  fullname: Ichinose, Masumi
– sequence: 11
  givenname: Kousuke
  surname: Noguchi
  fullname: Noguchi, Kousuke
– sequence: 12
  givenname: Yang
  surname: Liu
  fullname: Liu, Yang
– sequence: 13
  givenname: Sachio
  surname: Fushida
  fullname: Fushida, Sachio
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30914572$$D View this record in MEDLINE/PubMed
BookMark eNpVT1tLwzAYzcPEXfQvSP5AIU2aNnmUsXlhwz3o8_iSfp0ZbVKSCPrvregehAOHw7nAWZKZDx5nZMGEkgWrVTUny5TOjFWiYeqazAXTZSUbviD9IYaTDyk7S7dgc4iJho7uoXcnDz7TA0aXpzno6R5TyO_YuzAA3XyOk4PeYkudp88wgseE__MZ0gSX6Bp9xnhDrjroE97-8Yq8bTev68di9_LwtL7fFWeuZC5ajV1ZGqvRCNNh9yO4NMLy1ljVyro1iIJBrRsGlpmJOWopUTV8amm-Ine_u-OHGbA9jtENEL-Ol9v8G7IaWCc
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
ExternalDocumentID 30914572
Genre Journal Article
GroupedDBID 5GY
ACGFS
ALMA_UNASSIGNED_HOLDINGS
AUIBY
CGR
CUY
CVF
ECM
EIF
F5P
IPNFZ
MOJWN
NPM
REO
RIG
UDS
ID FETCH-LOGICAL-j285t-d9ef11bc9eb3bfeff11b25b3c2dbc8d56dbee30a6970ac0b6972e955e872bc992
ISSN 0385-0684
IngestDate Wed Oct 16 00:52:04 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j285t-d9ef11bc9eb3bfeff11b25b3c2dbc8d56dbee30a6970ac0b6972e955e872bc992
PMID 30914572
ParticipantIDs pubmed_primary_30914572
PublicationCentury 2000
PublicationDate 20190215
PublicationDateYYYYMMDD 2019-02-15
PublicationDate_xml – month: 02
  year: 2019
  text: 20190215
  day: 15
PublicationDecade 2010
PublicationPlace Japan
PublicationPlace_xml – name: Japan
PublicationTitle Gan to kagaku ryoho
PublicationTitleAlternate Gan To Kagaku Ryoho
PublicationYear 2019
SSID ssj0043708
Score 2.1948657
Snippet The current standard of treatment for malignant peritoneal mesothelioma(MPM)is cytoreductive surgery(CRS)plus perioperative intraperitoneal or systemic...
SourceID pubmed
SourceType Index Database
StartPage 395
SubjectTerms Chemotherapy, Adjuvant
Chemotherapy, Cancer, Regional Perfusion
Female
Humans
Hyperthermia, Induced
Male
Mesothelioma - diagnosis
Mesothelioma - therapy
Peritoneal Neoplasms - diagnosis
Peritoneal Neoplasms - therapy
Prognosis
Survival Rate
Title Prognostic Factors of Malignant Peritoneal Mesothelioma Experienced in Japanese Peritoneal Metastasis Center
URI https://www.ncbi.nlm.nih.gov/pubmed/30914572
Volume 46
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ3Lb9QwEIetLUioFwSi9AXIB26roDSx4-RYoS6rHiokWtGeWttxuuluklWbHOhfz4ydV6uCKJfsbux9KN_GMx7N_IaQz5qBWQYz58koSjyw0NJLmAw9nqYCK8JR4g6zLU6i-Rk7Pufnk8nVKGupqdUXff9kXcn_UIVzwBWrZJ9Btv9QOAHPgS8cgTAc_4nx99sK8-RQc3XW9s2xGS2r_BrzWzC9PUexbVt_e4e1Vqu8KuRI3xiVl6bHYDCxEeXD-bUExxHlSjAA3Obwtl7sN1gUwGddymu5bKa3v6pFNawepSka27xoetHUcjlkAslSSYv0qDB9XsdPmFFIF5uuq7tF3od85NJGcX8squa-asbRCSyICjxXn9lVZcUcG9uw8YrbBh3z0cbXLZ-ha7g5QrcuLLsQ3BrGXZOfv48-Us_uhjbIhoixtccJRnOcpWahsB0L-9-4SV518x_tMqy3cfqGvG63CfTQMX9LJqZ8R1YDb9ryplVGe9504EfHvOmIN81L2vF-OL_jTR3vLXI2Ozr9OvfabhneTRDz2ksTkx0cKJ0YFarMZPgi4CrUQap0nPIoVcaEvowS4UvtK3gMTMK5iUUA70qC9-RFCV-5Q2gUMsEyuIul0KgfKbnWIuCZMoIx4fu7ZNtdnMu1k0S57C7b3h9H9snm8P_4QF5mcA-aj-DQ1eqTpfIbo6lSkw
link.rule.ids 780
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prognostic+Factors+of+Malignant+Peritoneal+Mesothelioma+Experienced+in+Japanese+Peritoneal+Metastasis+Center&rft.jtitle=Gan+to+kagaku+ryoho&rft.au=Yonemura%2C+Yutaka&rft.au=Canbay%2C+Emel&rft.au=Wakama%2C+Satoshi&rft.au=Sako%2C+Shouzou&rft.date=2019-02-15&rft.issn=0385-0684&rft.volume=46&rft.issue=2&rft.spage=395&rft_id=info%3Apmid%2F30914572&rft_id=info%3Apmid%2F30914572&rft.externalDocID=30914572
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0385-0684&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0385-0684&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0385-0684&client=summon